Biophagy’s Business Modeljordan2022-01-25T21:51:57+00:00
Biophagy’s Business Model
Biophagy is managing a dual business model utilizing standard drug development programs in several therapeutic areas. It is also developing an over the counter (OTC) and/or direct to consumer (DTC) kit that will focus exclusively on autophagy stimulation and individual measurement of autophagy function over an extended period.
Proprietary Drug Discovery
Proprietary drug discovery with newly patented compounds developed for unmet medical needs, e.g., anti-microbial, neurodegenerative diseases.
An OTC kit with a rationally designed proprietary mix designed to stimulate and measure autophagy.